Please login to the form below

Not currently logged in
Email:
Password:

NICE reappoints chair, Professor Rawlins

The National Institute for Health and Clinical Excellence has reappointed Professor Sir Michael Rawlins as chairman for a further two years

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as chairman for a further two years.

Professor Rawlins, an honorary professor at the London School of Hygiene and Tropical Medicine, University of London, and emeritus professor at the University of Newcastle upon Tyne, has been chairman of NICE since it was established in 1999.

Commenting on his re-appointment, he said: "I am very happy to accept the Chair of the Board of NICE for a further two years. The Institute is entering an extremely exciting phase in its nearly 10-year history and I am very grateful for the opportunity to be able to continue to play a part in its continuing development."

Under the Code of Practice for Public Appointments chairs are only permitted to serve a maximum of ten years in office. The Commissioner has the power to grant exemptions in exceptional circumstances, and in this instance, Professor Rawlins' appointment has been made in accordance with the Office of the Commissioner for Public Appointments (OCPA) Code of Practice.

Andrew Dillon, CEO of NICE, said: "I am delighted that Sir Michael has been reappointed as the Institute's Chair. The next few years will be challenging for NICE as we grow in order to take on significant additional responsibilities as a result of Lord Darzi's NHS Next Stage Review."

12th March 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics